Therapeutic areas

We prioritise innovation to make the world’s diseases a thing of the past.

Two lab workers carrying out tasks

To get ahead of disease, we prioritise research into vaccines and medicines across our four therapeutic areas. We also remain open to opportunities outside these core areas where the science aligns with our strategic approach. 

RSV virus cell

Infectious diseases

For over 70 years we have been pioneering research methods to help protect people from infections.

HIV cell

HIV

Our work in HIV is carried out entirely through ViiV Healthcare, which GSK majority owns with Pfizer

Lupus cells

Immunology/ respiratory

We’re focused on unlocking the science of the immune system to understand how the body reacts.

Immuno Oncology science image

Oncology

Our expertise in oncology allows us to bring groundbreaking cancer therapies to our patients.

mRNA strand

Opportunity-driven

Our current opportunity-driven areas of focus.

Explore our innovation stories

 

Innovation is at the very core of GSK. Discover how we're uniting science, technology and talent to get ahead of disease together.

Behind the science

Tackling tomorrow’s health challenges today

GSK quality area team huddle

Behind the science

How adjuvants boost our immune response

R&D scientist walking through chemistry smart lab.

Behind the science

Fresh insights could finally help us tackle RSV

GSK quality lab team discussion around screens.

Behind the science

What if Remission were the Target of Lupus Care?

GSK quality lab team members collaborating and engaged in focussed task

Behind the science

Could tiny bubbles released from bacteria cells pave the way for new vaccine technology

Lab worker smiling

Continue to Infectious diseases

Back to top